Identification and Management of Adverse Reactions in Tuberculosis (TB) Treatment

James Gaensbauer, M.D., MScPH
Mayo Faculty: Zelalem Temesgen, M.D., and Tanner Johnson, Pharm.D., R.Ph.
August 21, 2025 - 12:00 - 1:00 p.m. Central Time - Live Webinar
This webinar reviews common and severe adverse reactions to medications used in the treatment of active tuberculosis. Participants will learn to recognize common and severe drug-related side effects and develop a general approach to managing these complications. The course aims to enhance clinical decision-making to ensure safe and effective TB therapy.
Target Audience
This course is designed for allied health professionals, nurses, nurse practitioners, physicians, physician assistants, resident/fellows, and healthcare professionals working in a public healthcare setting.
Learning Objectives
Upon Completion of this course, participants should be able to:
Differentiate between adverse drug reactions and disease-related complications in patients undergoing tuberculosis treatment to ensure accurate diagnosis and management.
Recognize both common and uncommon adverse reactions linked to first-line and second-line anti-tuberculosis drugs, with attention to their typical clinical features and onset patterns.
Adopt a general approach to identifying and managing adverse drug reactions
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge, or performance of any care or procedure(s) which may be discussed or taught in this course.
Broadcast in Central Time
Course Director
James Gaensbauer, M.D., MScPH
Mayo Faculty
Zelalem Temesgen, M.D. and Tanner Johnson, Pharm.D., R.Ph.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 1.00 ACPE Knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.
UAN Number: JA0000238-0000-25-027-L01-P
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
IPCE
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 1.00 ACPE
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Attendance
- 1.00 IPCE
Broadcast in Central Time
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Belonging and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.

Facebook
X
LinkedIn
Forward